Ulrika Essner retweeted
Before Abilify, I was housebound.
At 4mg, I was able to walk 0.2 miles to a bench near my house, rest, and walk back.
At 6mg, I was able to walk 0.5 miles, rest, and then back.
But the restlessness was too much, even at 5mg, so I have gone back down to 4.
#LongCovid #MECFS
I am now at 4mg of Abilify per day (up from 2 in Feb), and I am continuing to see benefits in energy and overall well-being.
I will up it to 6mg in a few weeks.
#LongCovid #MECFS
Ulrika Essner retweeted
Yet another study detected spike protein in both healthy (5) and LC (8) gut biopsies.
They used spatial transcriptomics to look at the gene expression levels in the gut tissue.
And significantly, this showed that LC patients had a different tissue phenotypes around spike. 1/3
Ulrika Essner retweeted
Psychologists’ Open Letter to Andy Burnham for Biomedical ME Research
- Only published yesterday afternoon, and it’s the most viewed post/page in the last 30 days. Please pass onto any UK psychologist you know.
humanisticsystems.com/me-ope…
Ulrika Essner retweeted
Submissions are still open for a few more weeks for the very severe ME photo gallery that @tink_ina and I are curating:
lcmedata.org/severephotos
We are particularly looking for high-quality, representative photos of Severe ME for projects, articles, and media to use to better represent the suffering of the disease using visuals. Some example submissions of the great ones we've gotten so far can be found below.
Tired of seeing the same lame stock photos of clearly healthy actors draping the back of their hands over their foreheads to represent ME?
@tink_ina and I feel the same way. That's why we're starting a photo gallery showcasing very severe patients that will be promoted to journalists and relevant organizations for use in articles and media.
We need your submissions to help curate the highest quality and most representative photos for this project. If you have photos of yourself or someone you take care of, please submit them: lcmedata.org/severephotos
Ulrika Essner retweeted
Regeneron’s Phase 2 trial in 82 POTS patients found that a single dose of baloncibart reduced standing heart rate by 11.4 bpm versus placebo and improved symptoms.
The antibody blocks NPR1, with biomarkers suggesting increased blood volume.
investor.regeneron.com/news-…
Ulrika Essner retweeted
The silent reality of Long Covid is that many patients are worsening, progressing or destabilising over time. Many progress from mild to moderate and severe.
Thank you to Molly and @AlastairFeeBBC for raising awareness.
bbc.co.uk/news/articles/c8p3…
Ulrika Essner retweeted
Excited to share ChronicleBio’s first clinical trial partnership, with Prolong Pharmaceuticals, evaluating PP-007 (Sanguinate) for post-exertional malaise in ME/CFS.
Heterogeneous diseases need this approach.
Today we are announcing our first clinical trial. We're joining forces with Prolong to evaluate a potential treatment for post exertional malaise (PEM) in #MECFS.
Sanguinate is an investigational intravenous therapy designed to deliver oxygen to deprived tissues, support blood flow, and reduce inflammation. The planned multi-site Phase 2a trial will evaluate the drug in at least 40 patients with first dosing expected mid-2027.
Most trials enroll patients based on symptoms alone, but recruitment for this study will leverage ChronicleBio's proprietary endotype intelligence platform to identify patients whose disease biology suggests they may be more likely to respond.
We are excited for our partnership with Prolong and grateful for the patient community that drives everything we do.
Read More: chroniclebio.com/news/chroni…
Ulrika Essner retweeted
“It's not just oh you know a bit forgot about, it has been like so drastically forgot about, it's unbelievable”
Former Olympic sprinter @BethDobbin on the neglect of #MECFS and the underfunding of research, comparing £6M for ME with £496M for dementia between 2019 and 2024.
Ulrika Essner retweeted
This almost makes me cry. We NEED more of this. $15 million is a great start on research. Long Covid is NOT going away. Finding biometrics and tests would be huge!
youtu.be/IxHlEJ3WUDs?is=IZyA…
Ulrika Essner retweeted
6 months in Germany! 🇩🇪🔬❤️
Months of hard work & new challenges! And next week, I'll be presenting our first results at a conference!
What if SARS-CoV-2 leaves more behind than we think?
Millions of people are still living with #LongCOVID, and we keep fighting to understand why.
Ulrika Essner retweeted
500 Athlete Signatures 🤩⭐️🏅
We’ve had so much interest since our initial athlete letter to the Prime Minister that we’ve now sent a second letter, this time with 500 athletes backing my call to meet with me and fund ME properly (prev 360).
Huge names including David Moyes (we know Andy’s an Everton fan 👀), Millie Bright & so many stars from a variety of sports 🙏🏼 I can’t tell you how grateful I am to every single one of you!!
Please @andyburnham , take an illness that’s been neglected more than almost anything else seriously 🙏🏼 1.35m people in the country estimated to be impacted, that’s a lot of the vote share!! @UKLabour
I know I owe lots of people replies and thanks, please bear with me and thank you so much again ❤️❤️❤️
Ulrika Essner retweeted
Die „Abnehmspritze“ (GLP-1) bei MCAS und ME/CFS? Ja – in Mikrodosierung.
GLP-1 ist ein Darmhormon. Aber seine Rezeptoren sitzen auch auf Immunzellen und auf Mastzellen. Genau da setzen die GLP-1s bei MCAS an.
Es geht hier nicht ums Abnehmen. Mit Mikrodosierung nutzen wir nur eine sehr geringe Dosis – so wenig wie möglich, um die Entzündung zu beruhigen.
In unserer ersten Fallserie (Afrin et al., Am J Med Sci 2025 – ich bin Co-Autorin) haben sich 89 % von 47 MCAS-Patienten deutlich gebessert: weniger Erschöpfung, weniger Brain Fog, weniger Schmerzen. Manche schon nach Stunden.
Das ist eine Fallserie, keine kontrollierte Studie. Mikrodosierung von GLP-1 ist bei MCAS und MECFS off-label – die Dosis wird ganz individuell bestimmt und im Verlauf angepasst.
arztpraxis-aschenbrenner.de/…
#MCAS #MECFS #GLP1 #Mikrodosierung #Tirzepatid
Ulrika Essner retweeted
Really interesting! Great to see this phenotyping work in #LongCovid 🔬
BioVie presented new findings from our Phase 2 ADDRESS-LC trial that suggest two distinct biomarker-defined #LongCOVID endotypes are associated with different patient responses to bezisterim treatment.
See details about our presentation at the @FNIH_Org @NIH RECOVER-TLC workshop here: investors.bioviepharma.com/n…
#LongCOVID $BIVI
Ulrika Essner retweeted
This is such a lonely illness. The person I’m forced to be is not the be person I am☹️ #MECFS
Ulrika Essner retweeted
It's ridiculous that in the past I could have more plans in a single random day than now in an entire year
Ulrika Essner retweeted
First time I’ve seen someone at a protest, actually speak with the correct amount of anger when discussing ME.
We need more of this and we need it to end up in front of the relevant people in person, not just online.
Wow!!! Pediatrician Dr. Maria Bea Merscher Alves delivers a fiery, visibly pissed-off speech condemning the ongoing neglect of children with ME.
We need all doctors, scientists, and politicians to speak out like this!!
Source: instagram.com/reels/DfJ7KLIx…
#pwme #kidswithME #MECFS
Ulrika Essner retweeted
Pip ist so alt wie Mila.
Sie ist ähnlich schwer an #MECFS erkrankt – und ähnlich lang.
Mit ihren Eltern bin ich seit Langem in Kontakt.
Überall dasselbe Elend.
Überall dieselbe Verzweiflung.
Überall dasselbe Abschieben von Verantwortung.
#NiemandSollSagenWirHabenEsNichtGewusst
Ulrika Essner retweeted
I made a new public list for anyone following long COVID, ME/CFS, POTS, and MCAS research.
Researchers like Akiko Iwasaki and @PutrinoLab, research groups like PolyBio and Open Medicine Foundation, patient-led groups like @patientled, plus people who dig into the actual papers, like ME/CFS Science and @JackHadfield14. Thank you to everyone on it for sharing your work so openly!
These conditions all overlap so much, and the good research is scattered all over. Having it in one feed makes it a lot easier to see what's new and what's actually holding up.
Who should I add?
nitter.gq/i/lists/21154604580773…
Ulrika Essner retweeted
“Every time there’s a wave, there’s another wave that’s going to follow with patients developing new onset long Covid,” said Akiko Iwasaki, an immunologist at Yale University. Gift article link. nytimes.com/2026/10/19/well/… @VirusesImmunity #LongCovid
Ulrika Essner retweeted
We’ve been blown away by the response to my interview with @BBCSport & @KatieFalkingham , thank you so much to everyone who has taken the time to read and engage with it ❤️ millions of views across multiple platforms really is immense.
We have since written to @andyburnham , calling on the @UKLabour government to fund research into this horrific illness. I know there’s so much more we could say, but with limited capacity, we’ve tried to focus on the lack of funding, resources in the NHS and how much it’s actually costing the government.
As you can see on the slides, it has been drastically underfunded compared to other illnesses and it is currently costing the UK Government far more than it would cost to fund research. ME is most often a post-viral illness. Therefore, since the start of the Covid pandemic, we’ve seen cases increase drastically and they will continue to increase. We need funding into research urgently. With estimates of people with ME being around 1.35 million, this is a lot of lives destroyed.
I’ve had thousands of messages on multiple platforms since sharing my story so please bear with me ❤️
Thanks to @ThereForME_UK and @wecrunchme for the stats.








































